Abbildung ähnlich
AESKULISA®
Referenz:
30-7206US
Bezeichnung:
β2-Glyco-GM
Verwendungszweck:

AESKULISA® ß2-Glyco-GM is a solid phase enzyme immunoassay employing native ß2 glycoprotein I highly purified from human plasma for the semiquantitative and qualitative detection of IgG and/or IgM antibodies against ß2 glycoprotein I in human serum. The presence of anti-ß2 glycoprotein I antibodies in conjunction with clinical findings and other laboratory results can be used as an aid in the diagnosis of thrombotic disorders related to primary and secondary antiphospholipid syndrome.

Methode:
ELISA
Konjugat:
IgG
,
IgM
Auswertung:
Qualitativ
,
Semi-quantitativ
Cut Off:
IgG: 15 IU/ml
,
IgM: 15 U/ml
Messbereich:
IgG: 0-300 IU/ml
,
IgM: 0-300 U/ml
Kalibrierung:
IgG: WHO International Standard anti-β2 Glycoprotein
Bestimmungen:
1 x 96
Kit-Konfiguration:
Single
Anzahl Antigene:
1
Registrierung:
FDA-cleared
Beschichtete Antigene:
ß2-Glykoprotein I
AESKULISA®

30-7206US

β2-Glyco-GM

Abbildung ähnlich
Verwendungszweck:

AESKULISA® ß2-Glyco-GM is a solid phase enzyme immunoassay employing native ß2 glycoprotein I highly purified from human plasma for the semiquantitative and qualitative detection of IgG and/or IgM antibodies against ß2 glycoprotein I in human serum. The presence of anti-ß2 glycoprotein I antibodies in conjunction with clinical findings and other laboratory results can be used as an aid in the diagnosis of thrombotic disorders related to primary and secondary antiphospholipid syndrome.

Methode:
ELISA
Konjugat:
IgG
,
IgM
Auswertung:
Qualitativ
,
Semi-quantitativ
Cut Off:
IgG: 15 IU/ml
,
IgM: 15 U/ml
Messbereich:
IgG: 0-300 IU/ml
,
IgM: 0-300 U/ml
Kalibrierung:
IgG: WHO International Standard anti-β2 Glycoprotein
Bestimmungen:
1 x 96
Kit-Konfiguration:
Single
Anzahl Antigene:
1
Registrierung:
FDA-cleared
Beschichtete Antigene:
ß2-Glykoprotein I
Downloads
Alle zugehörigen Dokumente und Informationen übersichtlich zusammengefasst

Gebrauchsanweisung